GSK to get $2.11bn from the sale of Lucozade and Ribena
Japan's SunJapan's Suntory Beverage & Food Ltd is to buy GlaxoSmithKline Plc's Lucozade and Ribena brands for 1.35 billion pounds ($2.11 billion) to broaden its soft drinks portfolio and help it expand into new markets.tory Beverage & Food Ltd is to buy GlaxoSmithKline Plc's Lucozade and Ribena brands for 1.35 billion pounds ($2.11 billion) to broaden its soft drinks portfolio and help it expand into new markets.
The sale will yield net proceeds of around 1.3 billion pounds, after tax, fees and costs, that will be used to reduce debt and for general corporate purposes.
Although the readthrough for AMRN is not straightforward, yet lower leverage at GSK could enable it to..........
David Redfern, GSK's chief strategy officer, said: “Lucozade and Ribena are iconic brands that have made a huge contribution to GSK over the years, but now is the right time to sell them as we increase the focus of our consumer healthcare business.”
Yeah jk, I know it's hard to comprehend for a low IQ minimum wage paid basher such as yourself, but AMRN will at least triple in price from here within the next year, and i hope within the next few months. But keep bashing since you need to eat more fast food - if you can obtain useful education past high school, maybe someday you can afford to take Vascepa to help lower the triglycerides you built up over the years of eating fast food while being paid minimum wage.